-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – EQ-101 in Alopecia Areata
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - EQ-101 in Alopecia Areata report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. EQ-101 in Alopecia Areata Drug Details: EQ-101 is under development for the...
-
Company Profile
China Tower Corp Ltd – Company Profile
China Tower Corp Ltd (China Tower) is a provider of telecommunications tower infrastructure services. It provides integrated wireless communications coverage solutions through a mix of small cells and macrocells. The company through its tower and indoor Distributed Antenna System (DAS) businesses provides service to telecommunications service providers (TSPs) and through the Trans-sector Site Application and Information (TSSAI) business provides tower site resource and data information services to different industries. China Tower offers maintenance services, power access, batteries or backup power...
Add to Basket -
Product Insights
Net Present Value Model: BNZ-1
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model BNZ-1 Drug Details EQ-101 is under...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – EQ-101
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry EQ-101 Drug Details EQ-101 is under development for the treatment of T-cell leukemias including...